Biotech · Private company
SyneuRx International (Taiwan) Corp
Track this companyFree. Adds SyneuRx International (Taiwan) Corp to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NaBen®Phase 3 · Refractory SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- NaBen®Phase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Pentarlandir™ UPPTAPhase 2 · Coronavirus Disease 2019ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19PHASE2 · UNKNOWN · started Aug 24, 2021ClinicalTrials.gov NCT04911777 · fetched Nov 12, 2026
- An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in AdultsPHASE2_PHASE3 · RECRUITING · started Mar 29, 2017ClinicalTrials.gov NCT03094429 · fetched Nov 12, 2026
- Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in AdultsPHASE2_PHASE3 · TERMINATED · started Mar 29, 2017ClinicalTrials.gov NCT02261519 · fetched Nov 12, 2026
- Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®PHASE2_PHASE3 · TERMINATED · started Jun 1, 2014ClinicalTrials.gov NCT01908192 · fetched Nov 12, 2026